1. Antiretroviral therapy switch : When to switch/ What to switch to ? Dr Ameet Dravid 2. Antiretroviral therapy : when to start? 3. DHHS guidelines 2013 4. HIVMAI Guidelines…

1. ANTIRETROVIRAL THERAPY IN 2012 AND ANTIRETROVIRAL THERAPY RESISTANCE DR AMEET DRAVID M.D (Med) AAHIVS (USA) RUBY HALL CLINIC and NOBLE HOSPITAL,PUNE 2. Antiretrovirals…

1. Title Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis The New England Journal of Medicine 367;16 nejm.1508 org october 18, 2012 Guide: Dr. Akhil…

1 Next-Generation Ion Torrent Sequencing of Drug Resistance 1 Mutations in Mycobacterium tuberculosis Strains 2 3 4 5 Luke T. Daum, Ph.D.1*, John D. Rodriguez, M.S.1, Sue…

Slide 1 HIV Drug Resistance Impact on ART for the Pregnant Woman Elliot Raizes, MD CDC Division of Global HIV/AIDS June 18, 2012 Slide 2 HIV Drug Resistance (HIVDR): Impact…

Slide 1 HIV Resistance Testing Clinical Implications Cyril K. Goshima, M.D. Director, AIDS Education Project June, 2009 Slide 2 I am a? 1. Physician 2. Nurse 3. Pharmacist…

Antiretroviral resistance is not an important risk of the oral tenofovir prophylaxis trial in Botswana: a simple mathematical modeling approach Dawn K. Smith, Poloko Kebaabetswe,…

Final Report: Track B AIDS 2010: Track B (Clinical Science) Highlights Dr. Andrew Kambugu, Uganda (Lead) Jain Vivek, USA Dr. Gabriel Chamie, USA Dr. Sabrina Kitaka-Bakera,…

Antiretroviral resistance is not an important risk of the oral tenofovir prophylaxis trial in Botswana: a simple mathematical modeling approach Dawn K. Smith, Poloko Kebaabetswe,…

Final Report: Track B AIDS 2010: Track B (Clinical Science) Highlights Dr. Andrew Kambugu, Uganda (Lead) Jain Vivek, USA Dr. Gabriel Chamie, USA Dr. Sabrina Kitaka-Bakera,…